Tests currently used to determine whether an unborn child has Down syndrome carry a small risk of miscarriage, but a new test for the genetic abnormality could solve that problem by getting results from a maternal blood sample. The test, expected on the market this year, analyzes fetal RNA and DNA in the maternal blood serum for specific genetic markers found on chromosome 21. The number of copies of each of these markers reveals whether the fetal DNA has an extra copy of the chromosome–the genetic variation that causes Down syndrome.
Cost: Not available
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
Don’t hold your breath for allergy-free cats
Gene-editing technology is eyed as the next step in the quest to create cats that don’t make you sneeze.
A better way to measure magnetic fields could make fetal heart problems easier to detect
Nobody had been able to build a practical device that worked at room temperature–until now.
First evidence that amino acids formed soon after the Big Bang
A new measurement of chemical evolution suggests that amino acids filled the early universe some nine billion years before life emerged. That has important implications for understanding the origin of life and attempting to re-create it in the lab.